Skip to main content

Oral evidence transcripts

Science and Technology Committee

Total results 57 (page 1 of 3)
21 July 2021
Inquiry The role of hydrogen in achieving Net Zero
Witnesses Guy Newey (Strategy and Performance Director at Energy Systems Catapult), Mark Neller (Director, Energy Business Leader UKIMEA at Arup), Kwasi Kwarteng (Secretary of State at Department for Business, Energy and Industrial Strategy), Professor Paul Monks (Chief Scientific Adviser at Department for Business, Energy and Industrial Strategy), and Sir Patrick Vallance, Government Chief Scientific Adviser
Committees Science and Technology Committee
Oral Evidence
7 July 2021
Inquiry The role of hydrogen in achieving Net Zero
Witnesses Professor Takeo Kikkawa (Distinguished fellow at Graduate School of International Management, International University of Japan.), Professor Katsuhiko Hirose (CEO and Chief Consultant at HyWealth Co, and Visiting Professor at I2CER (International Institute for Carbon-Neutral Energy Research), Kyushu University;), Franz Lehner (Head of Division International Cooperation at National Organisation Hydrogen and Fuel Cell Technology), Eric Heymann (Senior Economist at Deutsche Bank Research), Dr Martin Hanton (Technical Director at TÜV SÜD National Engineering Laboratory), and Dr Jane Dennett-Thorpe (Deputy Director of Decarbonisation and Energy Transition at Ofgem)
Committees Science and Technology Committee
Oral Evidence
30 June 2021
Work Biometrics and forensics: follow-up (Non-inquiry session)
Witnesses Professor Gillian Tully, former Forensic Science Regulator, Professor Paul Wiles, former Commissioner for the Retention and use of Biometric Material, Kit Malthouse (Minister of State for Crime and Policing at Home Office), Baroness Williams of Trafford (Minister of State for Countering Extremism at Home Office), and Dr Christophe Prince (Director of Data and Identity at Home Office)
Committees Science and Technology Committee
Oral Evidence
23 June 2021
Work Pre-appointment hearing: Government's preferred candidate for the UKRI Chair (Pre-appointment hearing)
Witnesses Sir Andrew Mackenzie (Government's preferred candidate for the role of Chair at UK Research and Innovation)
Committees Science and Technology Committee
Oral Evidence
16 June 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Wendy Barclay (Head of the Department of Infectious Disease at Imperial College London), Dr Susan Hopkins (Strategic Response Director, COVID-19 at Public Health England), and Professor Sir Andrew Pollard (Professor of Paediatric Infection and Immunity at University of Oxford, and Director at Oxford Vaccine Group)
Committees Science and Technology Committee
Oral Evidence
26 May 2021
Inquiry Coronavirus: lessons learnt
Witnesses Dominic Cummings, Former Chief Adviser to the Prime Minister
Committees Science and Technology Committee, and Health and Social Care Committee
Oral Evidence
10 June 2021
Inquiry Coronavirus: lessons learnt
Witnesses Matt Hancock (Secretary of State at Department for Health and Social Care)
Committees Science and Technology Committee, and Health and Social Care Committee
Oral Evidence
12 May 2021
Inquiry The role of hydrogen in achieving Net Zero
Witnesses Carl Arntzen (CEO at Bosch Thermotechnology Ltd), Professor Jianzhong Wu (Head of Engineering at Cardiff University), Antony Green (Hydrogen Project Director at National Grid), Angus McIntosh (Director of Energy Futures at SGN), Dr Angela Needle (Director of Strategy at Cadent), Professor Jon Gluyas (Executive Director at Durham Energy Institute), Dr Jonathan Radcliffe (Reader in Energy Systems and Policy at University of Birmingham), Professor Clare Grey (Geoffrey Moorhouse Gibson Professor at University of Cambridge), and Julian Leslie (Head of Networks at National Grid Electricity System Operator)
Committees Science and Technology Committee
Oral Evidence
28 April 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor John Aston (Harding Professor of Statistics in Public Life at University of Cambridge), Professor Sir Munir Pirmohamed (Chair at Commission on Human Medicines), Professor Anthony Harnden (Deputy Chair at Joint Committee on Vaccination and Immunisation), Dr Mary Ramsay (Head of Immunisation at Public Health England), Dr Ruth Payne (NIHR Academic Clinical Lecturer and Honorary Specialist Registrar in Infectious Diseases and Microbiology at University of Sheffield), Professor Christopher Dye (Professor of Epidemiology at University of Oxford), and Professor Ran Balicer (Director at Clalit Research Institute, and Professor of Public Health at Ben-Gurion University)
Committees Science and Technology Committee
Oral Evidence
21 April 2021
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Hetan Shah (Chief Executive at British Academy), Sir Adrian Smith (President at Royal Society), Hilary Reynolds CBE (Chief Executive at Association of Medical Research Charities), Naomi Weir (Head of Innovation at CBI), and Verity Davidge (Director of Central Policy at Make UK)
Committees Science and Technology Committee
Oral Evidence
14 April 2021
Inquiry The role of hydrogen in achieving Net Zero
Witnesses Gloria Esposito (Head of Sustainability at Zemo Partnership), Dave Rowlands (Fleet Engineering Director at Wincanton), Dr Helen McAllister (Strategy and Planning Director at Network Rail), Mike Muldoon (Head of Business Development, UK and Ireland at Alstom), Richard Clegg (Chief Executive at Lloyds Register Foundation), Morten Bo Christiansen (Vice President - Head of Decarbonisation at Maersk), Glenn Llewellyn (Vice President, Zero Emission Aircraft at Airbus), and Dr Brian Yutko (Chief Engineer for Sustainability and Future Mobility at Boeing)
Committees Science and Technology Committee
Oral Evidence
24 March 2021
Inquiry The role of hydrogen in achieving Net Zero
Witnesses Professor Marcus Newborough (Development Director at ITM Power), Tim Dumenil (Acorn Hydrogen Project Manager at Pale Blue Dot), Paul Booth (Chair at Tees Valley Local Enterprise Partnership), Dr Martin Pei (Executive Vice President and Chief Technical Officer at SSAB), and Dr Richard Leese (Director for Industrial Policy, Energy and Climate Change at Mineral Products Association)
Committees Science and Technology Committee
Oral Evidence
17 March 2021
Inquiry A new UK research funding agency
Witnesses Dominic Cummings, Former Chief Adviser to the Prime Minister, Kwasi Kwarteng (Secretary of State at Department for Business, Energy and Industrial Strategy), and Jo Shanmugalingam (Director General for Industrial Strategy, Science and Innovation at Department for Business, Energy and Industrial Strategy)
Committees Science and Technology Committee
Oral Evidence
9 March 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Chris Whitty, Chief Medical Officer for England, and Sir Patrick Vallance, Government Chief Scientific Adviser
Committees Science and Technology Committee
Oral Evidence
3 March 2021
Inquiry The role of hydrogen in achieving Net Zero
Witnesses Professor David Cebon (Professor of Mechanical Engineering at University of Cambridge), Professor Nilay Shah (Head of the Department of Chemical Engineering at Imperial College London), Michael Liebreich (CEO at Liebreich Associates), Dr Jenifer Baxter (Chief Engineer at Institution of Mechanical Engineers), and Baroness Brown of Cambridge (Chair at Carbon Trust, and Former Vice Chair at Climate Change Committee)
Committees Science and Technology Committee
Oral Evidence
24 February 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Anthony Harnden (Deputy Chair, Joint Committee on Vaccination and Immunisation and Professor of Primary Care at University of Oxford), Professor Wendy Barclay (Head of the Department of Infectious Disease at Imperial College London), Dr Philip Dormitzer (Vice President and Chief Scientific Officer of Viral Vaccines at Pfizer), Professor Sarah Gilbert (Professor of Vaccinology at University of Oxford), Madelaine McTernan (Director General at UK Vaccine Taskforce), and Nadhim Zahawi (Minister for COVID Vaccine Deployment at Department for Health and Social Care)
Committees Science and Technology Committee
Oral Evidence
17 February 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Dame Angela McLean (Professor of Mathematical Biology at University of Oxford, and Chief Scientific Adviser at Ministry of Defence), Professor Mark Woolhouse OBE (Professor of Infectious Disease Epidemiology at University of Edinburgh), Dr James Rubin (Professor of Psychology & Emerging Health Risks at Kings College London), Professor Sir John Bell (Regius Professor of Medicine at Oxford University), James Hetherington (Chief Data Science Adviser at Joint Biosecurity Centre), and Dr Johanna Hutchinson (Director for Data and Data Science at Joint Biosecurity Centre)
Committees Science and Technology Committee
Oral Evidence
3 February 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Baroness Harding of Winscombe (Interim Executive Chair at National Institute for Health Protection), Mark Hewlett (Director of Testing at NHS Test and Trace), and Steve McManus (Director of Tracing at NHS Test and Trace)
Committees Science and Technology Committee
Oral Evidence
27 January 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Greg Fell (Director of Public Health at Sheffield City Council), and Dr Richard Harling MBE (Director of Health and Care at Staffordshire County Council)
Committees Science and Technology Committee
Oral Evidence
26 January 2021
Inquiry Coronavirus: lessons learnt
Witnesses Sir Simon Stevens (Chief Executive at NHS England)
Committees Science and Technology Committee, and Health and Social Care Committee
Oral Evidence
Total results 57 (page 1 of 3)